Actively Recruiting

Age: 40Years +
All Genders
ID06447831

Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Multinational Validation Study in Adults with Chronic Obstructive Pulmonary Disease and Interstitial Lung Disease

Led by Laval University · Updated on 2024-06-07

82

Participants Needed

3

Research Sites

N/A

Total Duration

On this page

Sponsors

L

Laval University

Lead Sponsor

I

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate the 6-minute stepper test in adults aged 40 and older who have chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD). The study seeks to determine if the stepper test is valid compared to the 6-minute walk test and a maximal cardiopulmonary cycling test, whether the results are consistent when monitored directly in person or remotely via videoconferencing, and if the test is safe when performed at home with either monitoring method. Participants will attend two separate 3-hour laboratory visits where measurements like lung function and a cardiopulmonary exercise test on a cycle ergometer will be performed. They will also perform the 6-minute stepper test and the 6-minute walk test in random order with rest periods in between. Additionally, participants will have three 1-hour home visits to perform multiple stepper test trials; the first with a therapist present, and the next two either with direct or remote monitoring in random order. During the study, participants' health status and lung function will be monitored to ensure stability. The researchers will assess the validity and reliability of the stepper test by comparing it with other exercise tests and check for any adverse events. Participants will also provide feedback in interviews about their comfort and sense of safety while doing the stepper test. The study involves assessments over a period that may last up to two years for safety monitoring.

CONDITIONS

Brief Title

Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory Diseases

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 40 years or older
  • Diagnosis of chronic obstructive pulmonary disease (GOLD 2 to 4) or interstitial lung disease for more than 6 months
  • Clinically stable for at least 4 weeks
Not Eligible

You will not qualify if you...

  • Interstitial lung disease related to connective tissue disease or sarcoidosis with multisystem effects
  • Unstable or severe heart conditions
  • Severe rheumatologic or neurologic diseases that limit function
  • Weight above exercise equipment limits (e.g., over 130 kg for the stepper)
  • Any physical condition preventing safe exercise testing
  • Participation in another study requiring medication changes
  • Pulmonary rehabilitation within the past year
  • Use of oxygen therapy for lab testing arm
  • Participation in lab testing arm if joining home testing arm

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 6 to 18 days

Participants undergo laboratory testing including anthropometric measurements, pulmonary function tests, cardiopulmonary exercise testing, and spirometry to assess functional capacity.

Two 3-hour laboratory visits

Monitoring

Duration - 6 to 18 days

Participants perform the 6-minute step test (6MST) and 6-minute walk test (6MWT) in randomized order with rest periods to validate functional capacity measures.

Included in laboratory visits

Monitoring

Duration - 4 to 10 days

Participants complete three 1-hour home visits to perform the 6MST under direct or remote monitoring to assess test-retest reliability and perception of safety.

Three 1-hour home visits

Long-term Monitoring

Duration - Approximately 2 years

Participants are observed for adverse events and comfort during testing over an average of 2 years.

Follow-up contacts as needed

Trial Site Locations

Total: 3 locations

1

Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval

Québec, Canada, G1V 4G5

Actively Recruiting

2

Groupement des Hôpitaux de l'Institut Catholique de Lille

Lille, Hauts-de-France, France, 59000

Actively Recruiting

3

FormAction Santé

Pérenchies, Hauts-de-France, France, 59840

Not Yet Recruiting

Loading map...

Research Team

A

Alec Bass, PT, PhD

M

Marianne Belley

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

129Xe Gas Exchange MRI to Visualize Cardiopulmonary Function

Interstitial Lung Disease

Actively Recruiting

1 location

A Multicenter Prospective Study of Risk Factors in Progressi...

Interstitial Lung Disease

Actively Recruiting

1 location

A Randomized, Double-Blind, Placebo-Controlled, Multicenter ...

Interstitial Lung Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Assessing Functional Capacity in Directly and Remotely Monitored Home-Based Settings in Individuals With Chronic Respiratory Diseases: Protocol for a Multinational Validation Study.

Alec Bass, Sarah Géphine, Mickaël Martin...

https://pubmed.ncbi.nlm.nih.gov/38941132